Free Trial

Rezolute (RZLT) Competitors

Rezolute logo
$6.30 +0.43 (+7.33%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$6.36 +0.06 (+0.87%)
As of 07/25/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RZLT vs. IMCR, TARS, APGE, OCUL, VCEL, SPRY, ARQT, ADPT, SDGR, and JANX

Should you be buying Rezolute stock or one of its competitors? The main competitors of Rezolute include Immunocore (IMCR), Tarsus Pharmaceuticals (TARS), Apogee Therapeutics (APGE), Ocular Therapeutix (OCUL), Vericel (VCEL), ARS Pharmaceuticals (SPRY), Arcutis Biotherapeutics (ARQT), Adaptive Biotechnologies (ADPT), Schrodinger (SDGR), and Janux Therapeutics (JANX). These companies are all part of the "pharmaceutical products" industry.

Rezolute vs. Its Competitors

Rezolute (NASDAQ:RZLT) and Immunocore (NASDAQ:IMCR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk.

Rezolute has a net margin of 0.00% compared to Immunocore's net margin of -6.48%. Immunocore's return on equity of -5.86% beat Rezolute's return on equity.

Company Net Margins Return on Equity Return on Assets
RezoluteN/A -70.09% -63.08%
Immunocore -6.48%-5.86%-2.09%

Rezolute currently has a consensus target price of $11.83, indicating a potential upside of 87.83%. Immunocore has a consensus target price of $58.89, indicating a potential upside of 67.44%. Given Rezolute's stronger consensus rating and higher probable upside, analysts plainly believe Rezolute is more favorable than Immunocore.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rezolute
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14
Immunocore
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

In the previous week, Rezolute had 2 more articles in the media than Immunocore. MarketBeat recorded 4 mentions for Rezolute and 2 mentions for Immunocore. Immunocore's average media sentiment score of 1.30 beat Rezolute's score of 0.50 indicating that Immunocore is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rezolute
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Immunocore
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Rezolute has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Immunocore has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

83.0% of Rezolute shares are held by institutional investors. Comparatively, 84.5% of Immunocore shares are held by institutional investors. 18.4% of Rezolute shares are held by company insiders. Comparatively, 10.4% of Immunocore shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Immunocore has higher revenue and earnings than Rezolute. Immunocore is trading at a lower price-to-earnings ratio than Rezolute, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RezoluteN/AN/A-$68.46M-$1.15-5.48
Immunocore$310.20M5.70-$51.09M-$0.43-81.79

Summary

Rezolute and Immunocore tied by winning 8 of the 16 factors compared between the two stocks.

Get Rezolute News Delivered to You Automatically

Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RZLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RZLT vs. The Competition

MetricRezoluteMED IndustryMedical SectorNASDAQ Exchange
Market Cap$510.67M$3.07B$5.70B$9.50B
Dividend YieldN/A2.37%4.69%4.01%
P/E Ratio-5.4821.1828.1020.06
Price / SalesN/A283.55428.7189.10
Price / CashN/A42.7636.2258.56
Price / Book2.888.378.665.87
Net Income-$68.46M-$55.19M$3.25B$258.55M
7 Day Performance16.88%5.88%4.22%3.73%
1 Month Performance46.17%17.33%10.51%11.75%
1 Year Performance34.62%4.42%34.40%18.02%

Rezolute Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RZLT
Rezolute
2.5381 of 5 stars
$6.30
+7.3%
$11.83
+87.8%
+34.6%$510.67MN/A-5.4840News Coverage
Analyst Revision
IMCR
Immunocore
1.4778 of 5 stars
$36.93
+1.7%
$58.89
+59.5%
-12.4%$1.82B$310.20M-85.88320News Coverage
Positive News
TARS
Tarsus Pharmaceuticals
1.522 of 5 stars
$42.18
-2.5%
$66.67
+58.1%
+47.0%$1.82B$182.95M-15.4550
APGE
Apogee Therapeutics
3.3908 of 5 stars
$39.11
-0.5%
$99.00
+153.1%
-16.1%$1.81BN/A-10.8691Positive News
OCUL
Ocular Therapeutix
3.8788 of 5 stars
$11.52
+1.7%
$17.33
+50.5%
+47.5%$1.80B$63.72M-10.02230
VCEL
Vericel
3.6821 of 5 stars
$35.46
+0.3%
$61.14
+72.4%
-22.4%$1.78B$237.22M1,178.00300News Coverage
Positive News
Upcoming Earnings
SPRY
ARS Pharmaceuticals
3.085 of 5 stars
$17.85
-0.4%
$31.00
+73.7%
+59.7%$1.76B$89.15M-111.5690Positive News
ARQT
Arcutis Biotherapeutics
2.1447 of 5 stars
$14.34
-2.2%
$18.80
+31.1%
+47.1%$1.75B$196.54M-13.79150Positive News
Analyst Forecast
ADPT
Adaptive Biotechnologies
2.7823 of 5 stars
$10.31
-0.8%
$10.57
+2.5%
+148.3%$1.58B$178.96M-10.74790Positive News
SDGR
Schrodinger
2.0193 of 5 stars
$22.82
+6.4%
$32.75
+43.5%
-0.3%$1.57B$207.54M-8.68790Upcoming Earnings
Gap Up
JANX
Janux Therapeutics
2.471 of 5 stars
$26.08
-1.2%
$91.89
+252.3%
-39.3%$1.56B$10.59M-19.1830

Related Companies and Tools


This page (NASDAQ:RZLT) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners